{"title":"Colangitis biliar primaria","authors":"E. Buganza-Torio, Christian Navarro-Gerrard","doi":"10.24875/imids.m22000025","DOIUrl":null,"url":null,"abstract":"Primary biliary cholangitis is a chronic and progressive inflammatory autoimmune cholestatic liver disease characterized by the destruction of small intrahepatic bile ducts. It is considered a rare disease that predominates in women with a prevalence of 19 to 402 per million people. It is clinically characterized by fatigue, right upper quadrant pain, jaundice, pruritus, and biochemically with alkaline phosphatase (ALP) elevation at least > 1.5 times normal upper limit and the presence of mitochondrial antibody (AMA) positive at titers of 1:40 or more, liver biopsy is necessary in case of high suspicion and negative AMA or in case of suspected overlay syndrome (HAI/CBP). Early diagnosis and treatment of this disease can significantly improve the course of the disease by delaying liver cirrhosis and its complications and impacting patients’ quality of life.","PeriodicalId":424172,"journal":{"name":"Revista mexicana de enfermedades inflamatorias inmunomediadas","volume":"65 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista mexicana de enfermedades inflamatorias inmunomediadas","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24875/imids.m22000025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Primary biliary cholangitis is a chronic and progressive inflammatory autoimmune cholestatic liver disease characterized by the destruction of small intrahepatic bile ducts. It is considered a rare disease that predominates in women with a prevalence of 19 to 402 per million people. It is clinically characterized by fatigue, right upper quadrant pain, jaundice, pruritus, and biochemically with alkaline phosphatase (ALP) elevation at least > 1.5 times normal upper limit and the presence of mitochondrial antibody (AMA) positive at titers of 1:40 or more, liver biopsy is necessary in case of high suspicion and negative AMA or in case of suspected overlay syndrome (HAI/CBP). Early diagnosis and treatment of this disease can significantly improve the course of the disease by delaying liver cirrhosis and its complications and impacting patients’ quality of life.